Betrixaban
| Title | Journal |
|---|---|
| The role of factor Xa inhibitors in venous thromboembolism treatment. | Vascular health and risk management 20150101 |
| Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism. | Vascular health and risk management 20150101 |
| Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa). | European heart journal 20130521 |
| A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. | Nature medicine 20130401 |
| New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function. | Drugs 20120910 |
| ACP Journal Club: review: factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement. | Annals of internal medicine 20120821 |
| The new oral anticoagulants: a challenge for hospital formularies. | Hospital practice (1995) 20120801 |
| The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review. | Expert opinion on therapeutic patents 20120601 |
| Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation. | Discovery medicine 20120601 |
| Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents. | Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20120301 |
| Oral direct factor Xa inhibitors for stroke prevention in atrial fibrillation. | Nature reviews. Cardiology 20120227 |
| Stroke Prevention in Atrial Fibrillation: Where are We Now? | Clinical Medicine Insights. Cardiology 20120101 |
| Current status of new anticoagulants in the management of venous thromboembolism. | Advances in hematology 20120101 |
| Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants. | Journal of blood medicine 20120101 |
| Emerging anticoagulants. | Current medicinal chemistry 20120101 |
| Update on anti-coagulation in atrial fibrillation. | QJM : monthly journal of the Association of Physicians 20110901 |
| [Thromboembolic prophylaxis 2011: is warfarin on the wane?]. | Giornale italiano di cardiologia (2006) 20110901 |
| Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery. | Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 20110301 |
| New oral anticoagulants: should they replace heparins and warfarin? | Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20110101 |
| Role of factor xa inhibitors in cancer-associated thrombosis: any new data? | Advances in hematology 20110101 |
| Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments. | Journal of the American College of Cardiology 20101214 |
| New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors. | Clinics in chest medicine 20101201 |
| Factor Xa inhibitors: next-generation antithrombotic agents. | Journal of medicinal chemistry 20100909 |
| Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban. | Journal of clinical pharmacology 20100901 |
| Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation. | Current opinion in cardiology 20100701 |
| New anticoagulants for the prevention of venous thromboembolism. | Drug design, development and therapy 20100101 |
| Post-operative thromboprophylaxis: new oral thrombin and factor X inhibitors and their place in clinical practice. | F1000 medicine reports 20100101 |
| Emerging antithrombotic agents for thromboprophylaxis, clinical potential and patient considerations. | Journal of blood medicine 20100101 |
| Factor Xa inhibitors--new anticoagulants for secondary haemostasis. | Hamostaseologie 20090801 |
| New anticoagulants: focus on venous thromboembolism. | Current vascular pharmacology 20090701 |
| New anticoagulants for atrial fibrillation. | Seminars in thrombosis and hemostasis 20090701 |
| Rivaroxaban -- an oral, direct Factor Xa inhibitor: lessons from a broad clinical study programme. | European journal of haematology 20090501 |
| Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor. | Bioorganic & medicinal chemistry letters 20090415 |
| Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development. | Clinical pharmacokinetics 20090101 |
| A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT). | Thrombosis and haemostasis 20090101 |
| The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants. | Vascular health and risk management 20090101 |
| Emergence of new oral antithrombotics: a critical appraisal of their clinical potential. | Vascular health and risk management 20081201 |
| New oral anticoagulants in atrial fibrillation. | European heart journal 20080101 |
| Oral factor Xa inhibitors for venous thromboembolism prevention in major orthopedic surgery: a review. | Pathophysiology of haemostasis and thrombosis 20080101 |